The cost-utility of catheter ablation of atrial fibrillation: A systematic review and critical appraisal of economic evaluations

BMC Cardiovascular Disorders

Volumn 13, Issue , 2013, Pages

  Neyt, Mattias ^a   Van Brabandt, Hans ^a   Devos, Carl ^a  

^a BELGIAN HEALTH CARE KNOWLEDGE CENTRE KCE   (Belgium)

Author keywords

Atrial fibrillation; Catheter ablation; Cost Benefit analysis; Review

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; SOTALOL; WARFARIN;

ARTICLE; BLEEDING; CATHETER ABLATION; CEREBROVASCULAR ACCIDENT; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DATA BASE; DRUG WITHDRAWAL; ECONOMIC EVALUATION; HEART ATRIUM FIBRILLATION; HUMAN; LUNG TOXICITY; MORTALITY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSITIVITY ANALYSIS; SINUS RHYTHM; SYSTEMATIC REVIEW;

ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; BELGIUM; CATHETER ABLATION; COST-BENEFIT ANALYSIS; HUMANS;

EID: 84884765442     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/1471-2261-13-78     Document Type: Article

References (22)

1. Camm AJ, Kirchhof P, Lip GYH, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, et al. Guidelines for the management of atrial fibrillation. Europace 2010, 12(10):1360-1420.
2. Lafuente-Lafuente C, Mouly S, Longas-Tejero MA, Bergmann JF. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation. Cochrane Database Syst Rev 2007, 4:CD005049.
3. de Denus S, Sanoski CA, Carlsson J, Opolski G, Spinler SA. Rate vs rhythm control in patients with atrial fibrillation: a meta-analysis. Arch Intern Med 2005, 165(3):258-262. 10.1001/archinte.165.3.258, 15710787.
4. Testa L, Biondi-Zoccai GG, Dello Russo A, Bellocci F, Andreotti F, Crea F. Rate-control vs. rhythm-control in patients with atrial fibrillation: a meta-analysis. Eur Heart J 2005, 26(19):2000-2006. 10.1093/eurheartj/ehi306, 15872032.
5. Van Brabandt H, Neyt M, Devos C. Catheter ablation of atrial fibrillation. Health Technology Assessment (HTA) 2012, Brussels: Belgian Health Care Knowledge Centre (KCE), KCE Report 184C.
6. Assasi N, Blackhouse G, Xie F, Gaebel K, Robertson D, Hopkins R, Healey J, Roy D, Goeree R. Ablation procedures for rhythm control in patients with atrial fibrillation: clinical and cost-effectiveness analyses 2010, Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH).
7. Chan PS, Vijan S, Morady F, Oral H. Cost-effectiveness of radiofrequency catheter ablation for atrial fibrillation. J Am Coll Cardiol 2006, 47(12):2513-2520. 10.1016/j.jacc.2006.01.070, 16781382.
8. Eckard N, Davidson T, Walfridsson H, Levin LA. Cost-effectiveness of catheter ablation treatment for patients with symptomatic atrial fibrillation. J Atr Fibrillation 2009, 1(8):461-470.
9. McKenna C, Palmer S, Rodgers M, Chambers D, Hawkins N, Golder S, van Hout S, Pepper C, Todd D, Woolacott N. Cost-effectiveness of radiofrequency catheter ablation for the treatment of atrial fibrillation in the United Kingdom. Heart 2009, 95(7):542-549.
10. Ollendorf D, Silverstein M, Bobo T, Pearson S. Atrial fibrillation management options 2010, Boston: Institute for Clinical and Economic Review (ICER).
11. Reynolds MR, Zimetbaum P, Josephson ME, Ellis E, Danilov T, Cohen DJ. Cost-effectiveness of radiofrequency catheter ablation compared with antiarrhythmic drug therapy for paroxysmal atrial fibrillation. Circ Arrhythm Electrophysiol 2009, 2(4):362-369. 10.1161/CIRCEP.108.837294, 2760061, 19808491.
12. Rodgers M, McKenna C, Palmer S, Chambers D, Van Hout S, Golder S, Pepper C, Todd D, Woolacott N. Curative catheter ablation in atrial fibrillation and typical atrial flutter: systematic review and economic evaluation. Health Technol Assess 2008, 12(34). iii-iv, xi-xiii, 1-198.
13. Bonanno C, Paccanaro M, La Vecchia L, Ometto R, Fontanelli A. Efficacy and safety of catheter ablation versus antiarrhythmic drugs for atrial fibrillation: a meta-analysis of randomized trials. J Cardiovasc Med (Hagerstown) 2010, 11(6):408-418.
14. Parkash R, Tang AS, Sapp JL, Wells G. Approach to the catheter ablation technique of paroxysmal and persistent atrial fibrillation: a meta-analysis of the randomized controlled trials. J Cardiovasc Electrophysiol 2011, 22(7):729-738. 10.1111/j.1540-8167.2011.02010.x, 21332861.
15. Blomström Lundqvist C, Liliemark J, Eckerlund I. Catheter ablation for atrial fibrillation (update) 2010, Stockholm: The Swedish Council on Health Technology Assessment (SBU).
16. van Brabandt H, Neyt M, Devos C. Effectiveness of catheter ablation of atrial fibrillation in Belgian practice: a cohort analysis on administrative data. Europace 2013, 15(5):663-668. 10.1093/europace/eut004, 23388182.
17. Marshall DA, Levy AR, Vidaillet H, Fenwick E, Slee A, Blackhouse G, Greene HL, Wyse DG, Nichol G, O'Brien BJ. Cost-effectiveness of rhythm versus rate control in atrial fibrillation. Ann Intern Med 2004, 141(9):653-661. 10.7326/0003-4819-141-9-200411020-00005, 15520421.
18. Neyt M, Van Brabandt H. The importance of the comparator in economic evaluations: working on the efficiency frontier. Pharmacoeconomics 2011, 29(11):913-916. 10.2165/11595260-000000000-00000, 21988290.
19. Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, Kim YH, Klein G, Packer D, Skanes A. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation 2005, 111(9):1100-1105. 10.1161/01.CIR.0000157153.30978.67, 15723973.
20. Reynolds MR, Lavelle T, Essebag V, Cohen DJ, Zimetbaum P. Influence of age, sex, and atrial fibrillation recurrence on quality of life outcomes in a population of patients with new-onset atrial fibrillation: the Fibrillation Registry Assessing Costs, Therapies, Adverse events and Lifestyle (FRACTAL) study. Am Heart J 2006, 152(6):1097-1103. 10.1016/j.ahj.2006.08.011, 1820843, 17161061.
21. Jais P, Cauchemez B, Macle L, Daoud E, Khairy P, Subbiah R, Hocini M, Extramiana F, Sacher F, Bordachar P, et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation 2008, 118(24):2498-2505. 10.1161/CIRCULATIONAHA.108.772582, 19029470.
22. Wazni O, Wilkoff B, Saliba W. Catheter ablation for atrial fibrillation. N Engl J Med 2011, 365(24):2296-2304. 10.1056/NEJMct1109977, 22168644.